Follow
Katharina Ronacher
Katharina Ronacher
Professor, Mater Medical Research - The University of Queensland
Verified email at mater.uq.edu.au
Title
Cited by
Cited by
Year
Immunological biomarkers of tuberculosis
G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla
Nature Reviews Immunology 11 (5), 343-354, 2011
6282011
Genital inflammation and the risk of HIV acquisition in women
L Masson, JAS Passmore, LJ Liebenberg, L Werner, C Baxter, KB Arnold, ...
Clinical Infectious Diseases 61 (2), 260-269, 2015
4262015
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
ST Malherbe, S Shenai, K Ronacher, AG Loxton, G Dolganov, M Kriel, ...
Nature medicine 22 (10), 1094-1100, 2016
2712016
Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response
JM Cliff, JS Lee, N Constantinou, JE Cho, TG Clark, K Ronacher, EC King, ...
The Journal of infectious diseases 207 (1), 18-29, 2013
2672013
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa
K Mlisana, N Naicker, L Werner, L Roberts, F Van Loggerenberg, ...
The Journal of infectious diseases 206 (1), 6-14, 2012
2342012
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes
R Roy Chowdhury, F Vallania, Q Yang, CJ Lopez Angel, F Darboe, ...
Nature 560 (7720), 644-648, 2018
2322018
Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study
L Masson, K Mlisana, F Little, L Werner, NN Mkhize, K Ronacher, ...
Sexually transmitted infections 90 (8), 580-587, 2014
2002014
Host blood RNA signatures predict the outcome of tuberculosis treatment
EG Thompson, Y Du, ST Malherbe, S Shankar, J Braun, J Valvo, ...
Tuberculosis 107, 48-58, 2017
1682017
Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction
K Ronacher, K Hadley, C Avenant, E Stubsrud, SS Simons Jr, A Louw, ...
Molecular and cellular endocrinology 299 (2), 219-231, 2009
1642009
Synthetic progestins used in HRT have different glucocorticoid agonist properties
D Koubovec, K Ronacher, E Stubsrud, A Louw, JP Hapgood
Molecular and cellular endocrinology 242 (1-2), 23-32, 2005
1532005
Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus
K Ronacher, SA Joosten, R van Crevel, HM Dockrell, G Walzl, ...
Immunological reviews 264 (1), 121-137, 2015
1352015
Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatment
I Honeyborne, TD McHugh, PPJ Phillips, S Bannoo, A Bateson, N Carroll, ...
Journal of clinical microbiology 49 (11), 3905-3911, 2011
1282011
Regulation of expression of mammalian gonadotrophin‐releasing hormone receptor genes
JP Hapgood, H Sadie, W Van Biljon, K Ronacher
Journal of neuroendocrinology 17 (10), 619-638, 2005
1272005
Assessment of validity of a blood-based 3-gene signature score for progression and diagnosis of tuberculosis, disease severity, and treatment response
HC Warsinske, AM Rao, FMF Moreira, PCP Santos, AB Liu, M Scott, ...
JAMA network open 1 (6), e183779-e183779, 2018
1112018
Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis
C Riou, B Perez Peixoto, L Roberts, K Ronacher, G Walzl, C Manca, ...
PloS one 7 (5), e36886, 2012
1102012
Diabetes mellitus among pulmonary tuberculosis patients from 4 tuberculosis-endemic countries: the TANDEM study
C Ugarte-Gil, B Alisjahbana, K Ronacher, AL Riza, RC Koesoemadinata, ...
Clinical Infectious Diseases 70 (5), 780-788, 2020
992020
Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 1: epidemiology and clinical management
JA Critchley, BI Restrepo, K Ronacher, A Kapur, AA Bremer, ...
Chest 152 (1), 165-173, 2017
992017
Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 2: underlying biologic mechanisms
K Ronacher, R van Crevel, JA Critchley, AA Bremer, LS Schlesinger, ...
Chest 152 (1), 174-180, 2017
832017
Biomarkers for TB treatment response: challenges and future strategies
G Walzl, K Ronacher, JFD Siawaya, HM Dockrell
Journal of Infection 57 (2), 103-109, 2008
822008
Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response
JFD Siawaya, NB Bapela, K Ronacher, H Veenstra, M Kidd, R Gie, ...
Journal of Infection 56 (5), 340-347, 2008
792008
The system can't perform the operation now. Try again later.
Articles 1–20